An enhanced process for evaluating and publishing evidence for "off-label" uses of medications has been launched through a collaborative initiative with the Foundation for Evidence-Based Medicine (FEBM) and the American Society of Health-System Pharmacists (ASHP), which publishes AHFS Drug Information (AHFS DI). AHFS DI is recognized by the U.S.
More...